Cite
HARVARD Citation
Hasni, S. et al. (2019). Safety and Tolerability of Omalizumab: A Randomized Clinical Trial of Humanized Anti‐IgE Monoclonal Antibody in Systemic Lupus Erythematosus. Arthritis & rheumatology. 71 (7), pp. 1135-1140. [Online].